This item is under embargo and not available online per the author's request. For access information, please visit http://libanswers.wustl.edu/faq/5640.
Copper-64 Labeled Somatostatin Analogs as Imaging and Therapeutic Agents
Date of Award
Doctor of Philosophy (PhD)
The goal of this research is to develop 64Cu radiolabeled somatostatin-receptor ligands for position emission tomography (PET) imaging and radiotherapy of cancer. Copper-64 radiopharmaceuticals have been used as PET imaging agents for various diseases because of the favorable decay characteristics of 64Cu (t1/2 = 12.7 h; β+ (17.8%); β- (38.4%)).
Chair and Committee
Carolyn J. Anderson
William E. Buhro, Sophia E. Hayes, Suzanne E. Lapi, Liviu M. Mirica, Buck E. Rogers
Nguyen, Kim Ngoc, "Copper-64 Labeled Somatostatin Analogs as Imaging and Therapeutic Agents" (2010). Arts & Sciences Electronic Theses and Dissertations. 176.